Christopher Benz

Christopher Benz

UNVERIFIED PROFILE

Are you Christopher Benz?   Register this Author

Register author
Christopher Benz

Christopher Benz

Publications by authors named "Christopher Benz"

Are you Christopher Benz?   Register this Author

99Publications

1985Reads

11Profile Views

Discovery of internalizing antibodies to basal breast cancer cells.

Protein Eng Des Sel 2018 01;31(1):17-28

Department of Anesthesia and Perioperative Care, University of California, San Francisco Rm 3C-38, Zuckerberg San Francisco General Hospital and Trauma Center, 1001 Potrero Ave, San Francisco, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/protein/gzx063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283401PMC
January 2018

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.

Breast Cancer Res Treat 2017 Nov 4;166(2):593-601. Epub 2017 Aug 4.

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4428-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668340PMC
November 2017

Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study.

Cancer Causes Control 2017 Oct 18;28(10):1027-1032. Epub 2017 Aug 18.

Buck Institute for Research on Aging, Novato, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-017-0942-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613056PMC
October 2017

Comment on: 'Hypertensive diseases in pregnancy and breast cancer risk'.

Br J Cancer 2016 05 3;114(11):e10. Epub 2016 May 3.

Child Health and Development Studies of the Public Health Institute, Berkeley, CA 94709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.81DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891511PMC
May 2016

Targeting Molecular Aberrations in Breast Cancer: Is It about Time?

Am Soc Clin Oncol Educ Book 2012 :186-91

From the Carol Franc Buck Breast Care Center, University of California, San Francisco; Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, CA; Breast Cancer Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.186DOI Listing
April 2016

FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.

Breast Cancer Res Treat 2015 Nov 12;154(1):23-32. Epub 2015 Oct 12.

Buck Institute for Research on Aging, 8001 Redwood Blvd., Novato, CA, 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3589-7DOI Listing
November 2015

DGCR8 is essential for tumor progression following PTEN loss in the prostate.

EMBO Rep 2015 Sep 23;16(9):1219-32. Epub 2015 Jul 23.

The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California - San Francisco, San Francisco, CA, USA Center for Reproductive Sciences, University of California - San Francisco, San Francisco, CA, USA Department of Urology, University of California - San Francisco, San Francisco, CA, USA Department of Anatomic Pathology, University of California - San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/embr.201439925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576988PMC
September 2015

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Breast Cancer Res Treat 2014 Apr 22;144(2):287-298. Epub 2014 Feb 22.

Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2877-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318538PMC
April 2014

FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.

Breast Cancer Res Treat 2013 Jun 28;139(2):381-90. Epub 2013 May 28.

Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2556-4DOI Listing
June 2013

Age-related micro-RNA abundance in individual C. elegans.

Aging (Albany NY) 2013 Jun;5(6):394-411

Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824409PMC
http://dx.doi.org/10.18632/aging.100564DOI Listing
June 2013

PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis.

Bioinformatics 2012 Sep;28(18):i640-i646

Department of Biomolecular Engineering and CBSE, University of California Santa Cruz, Santa Cruz, CA 95064, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/bts402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436829PMC
September 2012

Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers.

Breast Cancer Res Treat 2011 Apr 12;126(3):803-10. Epub 2011 Jan 12.

Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-011-1345-1
Publisher Site
http://dx.doi.org/10.1007/s10549-011-1345-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337964PMC
April 2011

ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.

Cancer Res 2010 May 20;70(9):3709-17. Epub 2010 Apr 20.

Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-3768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862137PMC
May 2010

Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.

BMC Public Health 2010 Apr 30;10:228. Epub 2010 Apr 30.

County of Marin, Department of Health and Human Services, 20 North San Pedro Road, San Rafael, CA 94903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-10-228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876106PMC
April 2010

Development of a highly stable and targetable nanoliposomal formulation of topotecan.

J Control Release 2010 Jan 15;141(1):13-21. Epub 2009 Aug 15.

Hermes Biosciences, Inc., 61 Airport Boulevard, Suite D, South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2009.08.006DOI Listing
January 2010

Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.

Clin Cancer Res 2009 May 21;15(9):3163-71. Epub 2009 Apr 21.

Department of Laboratory Medicine, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746548PMC
May 2009

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.

Cancer Res 2009 Feb 3;69(4):1279-83. Epub 2009 Feb 3.

Department of Pathology, Comprehensive Cancer Center, and National Foundation for Cancer Research, University of Alabama at Birmingham, Birmingham, Alabama 35294-0019, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-3559DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754225PMC
February 2009

Ageing, oxidative stress and cancer: paradigms in parallax.

Nat Rev Cancer 2008 Nov;8(11):875-9

Christopher C. Benz and Christina Yau are at the Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603471PMC
November 2008

Unraveling the biologic and clinical complexities of HER2.

Clin Breast Cancer 2008 Oct;8(5):392-401

Comprehensive Cancer Center, University of California, San Francisco, CA 94115-1710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.047DOI Listing
October 2008

Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.

Cancer Epidemiol Biomarkers Prev 2008 May 7;17(5):1028-33. Epub 2008 May 7.

Department of Surgery, Kaiser Permanente Oakland Medical Center, Oakland, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-07-0726DOI Listing
May 2008

Impact of aging on the biology of breast cancer.

Crit Rev Oncol Hematol 2008 Apr 18;66(1):65-74. Epub 2007 Oct 18.

Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2007.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626623PMC
April 2008

Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

Mol Cancer Ther 2007 Oct;6(10):2737-46

Department of Anesthesia, University of California at San Francisco, Room 3C38, 1001 Potrero Avenue, San Francisco, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0140DOI Listing
October 2007

Anti-oncomir suppression of tumor phenotypes.

Mol Interv 2007 Aug;7(4):199-202, 180

Department of Medicine, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://mr.crossref.org/iPage?doi=10.1124%2Fmi.7.4.6
Publisher Site
http://dx.doi.org/10.1124/mi.7.4.6DOI Listing
August 2007

Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer.

Mol Pharmacol 2007 Jun 28;71(6):1525-34. Epub 2007 Mar 28.

Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://molpharm.aspetjournals.org/cgi/doi/10.1124/mol.107.03
Publisher Site
http://dx.doi.org/10.1124/mol.107.034090DOI Listing
June 2007

Quantification of cysteine oxidation in human estrogen receptor by mass spectrometry.

Anal Chem 2007 Apr 21;79(8):3083-90. Epub 2007 Mar 21.

Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ac062154oDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536661PMC
April 2007

Type and duration of exogenous hormone use affects breast cancer histology.

Ann Surg Oncol 2007 Feb 14;14(2):695-703. Epub 2006 Nov 14.

Department of Surgery, Kaiser Permanente Oakland Medical Center, Oakland, California, 94602, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-006-9129-2DOI Listing
February 2007

Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

J Biol Chem 2007 Jan 16;282(2):1479-86. Epub 2006 Nov 16.

Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M609383200
Publisher Site
http://dx.doi.org/10.1074/jbc.M609383200DOI Listing
January 2007

Novel pathways associated with quinone-induced stress in breast cancer cells.

Drug Metab Rev 2006 ;38(4):601-13

Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0360253060095939
Publisher Site
http://dx.doi.org/10.1080/03602530600959391DOI Listing
January 2007

Breast cancer growth prevention by statins.

Cancer Res 2006 Sep;66(17):8707-14

Department of Surgery, University of California San Francisco/Mt. Zion Medical Center, Room C342, 1600 Divisadero, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-4061DOI Listing
September 2006

Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.

J Clin Oncol 2006 Sep;24(26):4245-53

Swiss Institute for Experimental Cancer Research, National Center of Competence in Research, Molecular Oncology, Riehen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.1912DOI Listing
September 2006

Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription.

Assay Drug Dev Technol 2006 Jun;4(3):273-84

Program of Cancer and Development Therapeutics, Buck Institute for Age Research, Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/adt.2006.4.273DOI Listing
June 2006

Clinical trials are required to prove the chemopreventive worth of statins.

Arch Intern Med 2006 May;166(10):1143; author reply 1144

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.166.10.1143-aDOI Listing
May 2006

Identification of an epithelial-specific enhancer regulating ESX expression.

Gene 2006 Feb 22;367:118-25. Epub 2005 Nov 22.

Cancer Research Institute, University of California San Francisco, Box 0808, San Francisco, CA 94143-0808, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2005.10.001DOI Listing
February 2006

Rapid alteration of microRNA levels by histone deacetylase inhibition.

Cancer Res 2006 Feb;66(3):1277-81

Program of Cancer and Developmental Therapeutics, Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-3632DOI Listing
February 2006

Reactivity of zinc finger cysteines: chemical modifications within labile zinc fingers in estrogen receptor.

J Am Soc Mass Spectrom 2005 Dec 24;16(12):2017-26. Epub 2005 Oct 24.

Buck Institute for Age Research, Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1016/j.jasms.2005.08.009
Publisher Site
http://dx.doi.org/10.1016/j.jasms.2005.08.009DOI Listing
December 2005

Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation.

Mol Pharmacol 2005 Sep 6;68(3):606-15. Epub 2005 Jun 6.

Program of Cancer and Developmental Therapeutics, Buck Institute for Age Research, 8001 Red-wood Blvd., Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://molpharm.aspetjournals.org/cgi/doi/10.1124/mol.105.01
Publisher Site
http://dx.doi.org/10.1124/mol.105.013474DOI Listing
September 2005

Hyperplasia, reduced E-cadherin expression, and developmental arrest in mammary glands oxidatively stressed by loss of mitochondrial superoxide dismutase.

Breast 2005 Aug 19;14(4):256-63. Epub 2005 Apr 19.

Department of Anatomy, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2005.02.004DOI Listing
August 2005

Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.

Int J Biochem Cell Biol 2005 May;37(5):1130-44

Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2004.09.006DOI Listing
May 2005

Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.

Clin Cancer Res 2005 May;11(9):3392-401

Hermes Biosciences, Inc., South San Francisco, Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2445DOI Listing
May 2005

Risk factors for estrogen receptor-positive breast cancer.

Arch Surg 2005 Jan;140(1):58-62

Department of Surgery, University of California, San Francisco, Cancer Center, 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.140.1.58DOI Listing
January 2005

Future directions of liposome- and immunoliposome-based cancer therapeutics.

Semin Oncol 2004 Dec;31(6 Suppl 13):196-205

UCSF Comprehensive Cancer Center, San Francisco, CA 94115-1710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2004.08.009DOI Listing
December 2004

Development of ligand-targeted liposomes for cancer therapy.

Expert Opin Ther Targets 2004 Aug;8(4):335-53

University of California at San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.8.4.335DOI Listing
August 2004

Geographic excess of estrogen receptor-positive breast cancer.

Cancer Epidemiol Biomarkers Prev 2003 Dec;12(12):1523-7

Cancer and Developmental Therapeutics Program, Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
December 2003

Essential cysteine-alkylation strategies to monitor structurally altered estrogen receptor as found in oxidant-stressed breast cancers.

Anal Biochem 2003 Sep;320(1):21-31

Buck Institute for Age Research (Program of Cancer and Developmental Therapeutics), Novato, CA 94945, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-2697(03)00296-3DOI Listing
September 2003

Age-dependent changes in breast cancer hormone receptors and oxidant stress markers.

Breast Cancer Res Treat 2002 Dec;76(3):221-36

Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1020886801674DOI Listing
December 2002

Age-associated biomarker profiles of human breast cancer.

Int J Biochem Cell Biol 2002 Nov;34(11):1318-30

Stiftung Tumorbank Basel and Department of Research, University Clinics, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1357-2725(02)00052-3DOI Listing
November 2002

Redox control of zinc finger proteins.

Methods Enzymol 2002 ;353:54-69

Mass Spectrometry Facility, Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0076-6879(02)53036-6DOI Listing
August 2002

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis.

Biochim Biophys Acta 2002 Aug;1591(1-3):109-118

Department of Anesthesia and Pharmaceutical Chemistry, University of California-San Francisco, SF General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-4889(02)00256-2DOI Listing
August 2002

Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.

Mol Cancer Ther 2002 Apr;1(6):385-92

Program of Cancer and Development Therapeutics, Buck Institute for Age Research, Novato, California 94945, USA.

View Article

Download full-text PDF

Source
April 2002